Consequently, downregulation of MFN2 using CRISPR/Cas9 or siRNA increased thyroid cancer cell invasion and migration by inducing EMT, and this was associated with activation of the AKT signaling pathway. This evidence concerns the gene MFN2 and thyroid cancer.